The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from government-funded contracts and authorize the Trump administration to bar US ...

The drug and biotech sector witnessed a see-saw performance in 2025. After a weak show for most of the year, the sector ...

Learn more about whether Legend Biotech Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...

First, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) seeks daily investment results, before fees and expenses, of 300% of the performance of the aforementioned biotech index. Second, the ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs with high cash burn and no revenue. Biotech IPOs show resilience. Recent market debuts ...

European VC firm Kurma Partners has unveiled its latest biotech fund, with 140 million euros ($154 million) raised so far and three biotech beneficiaries already named. Kurma plans to raise a total of ...

NDAA package revives stalled measures on US outbound investment and biotech, signalling Capitol Hill’s hardened stance towards Beijing.

HOLLY SPRINGS, N.C. (WTVD) -- Governor Josh Stein spoke at the NCBioTech Summit in Charlotte, touting recent investment in the life sciences industry across the state. It comes less than one month ...

Global medtech and biotech investment fell from $133.8 billion in 2021 to $89.7 billion in 2022, according to investment data from dealroom.co. The 2021 bull market for medtech investment cooled in ...